Reduced sensitivity to the locomotor-stimulant effects of cocaine is associated with increased sensitivity to its discriminative stimulus properties

Behavioural Pharmacology

Volumn 20, Issue 1, 2009, Pages 67-77

  Klein, David A ^a   Gulley, Joshua M ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Behavioral sensitization; Cocaine; Discriminative stimulus; DOI; Fluoxetine; Individual differences; Open field activity; Rat

Indexed keywords

COCAINE; FLUOXETINE; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; 4-IODO-2,5-DIMETHOXYPHENYLISOPROPYLAMINE; AMPHETAMINE DERIVATIVE; SEROTONIN 2A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN AGONIST;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; LOCOMOTION; MALE; NONHUMAN; RAT; STIMULUS GENERALIZATION; ANIMAL; DISCRIMINATION LEARNING; DRUG COMBINATION; DRUG POTENTIATION; INSTRUMENTAL CONDITIONING; LEARNING; LONG EVANS RAT; MOTOR ACTIVITY; REINFORCEMENT;

AMPHETAMINES; ANIMALS; COCAINE; CONDITIONING, OPERANT; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FLUOXETINE; GENERALIZATION, STIMULUS; MOTOR ACTIVITY; RATS; RATS, LONG-EVANS; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTOR, SEROTONIN, 5-HT2C; REINFORCEMENT SCHEDULE; SEROTONIN AGONISTS;

EID: 61449199463     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e3283242fdd     Document Type: Article

References (60)

1. Allen RM, Everett CV, Nelson AM, Gulley JM, Zahniser NR (2007). Low and high locomotor responsiveness to cocaine predicts intravenous cocaine conditioned place preference in male Sprague-Dawley rats. Pharmacol Biochem Behav 86:37-44.
2. Baker LE, Riddle EE, Saunders RB, Appel JB (1993). The role of monoamine uptake in the discriminative stimulus effects of cocaine and related compounds. Behav Pharmacol 4:69-79.
3. Bevins RA, Klebaur JE, Bardo MT (1997). Individual differences in response to novelty, amphetamine-induced activity and drug discrimination in rats. Behav Pharmacol 8:113-123.
4. Branch CA, Knuepfer MM (1994). Causes of differential cardiovascular sensitivity to cocaine. I: Studies in conscious rats. J Pharmacol Exp Ther 269:674-683.
5. Briegleb SK, Gulley JM, Hoover BR, Zahniser NR (2004). Individual differences in cocaine- and amphetamine-induced activation of male Sprague-Dawley rats: contribution of the dopamine transporter. Neuropsychopharmacology 29:2168-2179.
6. Broadbent J, Michael EK, Riddle EE, Apple JB (1991). Involvement of dopamine uptake in the discriminative stimulus effects of cocaine. Behav Pharmacol 2:187-197.
7. Browman KE, Badiani A, Robinson TE (1998). The influence of environment on the induction of sensitization to the psychomotor activating effects of intravenous cocaine in rats is dose-dependent. Psychopharmacology (Berl) 137:90-98.
8. Bubar MJ, Cunningham KA (2006). Serotonin 5-HT2A and 5-HT2C receptors as potential targets for modulation of psychostimulant use and dependence. Curr Top Med Chem 6:1971-1985.
9. Callahan PM, Cunningham KA (1997). Modulation of the discriminative stimulus properties of cocaine: comparison of the effects of fluoxetine with 5-HT1A and 5-HT1B receptor agonists. Neuropharmacology 36:373-381.
10. Callahan PM, De la Garza R 2nd, Cunningham KA (1994). Discriminative stimulus properties of cocaine: modulation by dopamine D1 receptors in the nucleus accumbens. Psychopharmacology (Berl) 115:110-114.
11. Callahan PM, De La Garza R 2nd, Cunningham KA (1997). Mediation of the discriminative stimulus properties of cocaine by mesocorticolimbic dopamine systems. Pharmacol Biochem Behav 57:601-607.
12. Carey RJ, DePalma G, Damianopoulos E (2001). Cocaine and serotonin: a role for the 5-HT(1 A) receptor site in the mediation of cocaine stimulant effects. Behav Brain Res 126:127-133.
13. Carey RJ, DePalma G, Damianopoulos E, Shanahan A, Muller CP, Huston JP (2005). Evidence that the 5-HT1A autoreceptor is an important pharmacological target for the modulation of cocaine behavioral stimulant effects. Brain Res 1034:162-171.
14. Colpaert FC, Niemegeers CJ, Janssen PA (1976). Theoretical and methodological considerations on drug discrimination learning. Psychopharmacologia 46:169-177.
15. Cunningham KA, Callahan PM (1991). Monoamine reuptake inhibitors enhance the discriminative state induced by cocaine in the rat. Psychopharmacology (Berl) 104:177-180.
16. Filip M, Cunningham KA (2002). Serotonin 5-HT(2C) receptors in nucleus accumbens regulate expression of the hyperlocomotive and discriminative stimulus effects of cocaine. Pharmacol Biochem Behav 71:745-756.
17. Filip M, Nowak E, Papla I, Przegalinski E (2001). Role of 5-hydroxytryptamine1B receptors and 5-hydroxytryptamine uptake inhibition in the cocaine-evoked discriminative stimulus effects in rats. J Physiol Pharmacol 52:249-263.
18. Filip M, Bubar MJ, Cunningham KA (2006). Contribution of serotonin (5-HT) 5-HT2 receptor subtypes to the discriminative stimulus effects of cocaine in rats. Psychopharmacology (Berl) 183:482-489.
19. Fiorella D, Palumbo PA, Rabin RA, Winter JC (1995). The time-dependent stimulus effects of R(-)-2,5-dimethoxy-4-methamphetamine (DOM): implications for drug-induced stimulus control as a method for the study of hallucinogenic agents. Psychopharmacology (Berl) 119:239-245.
20. Gauvin DV, Young AM (1989). Evidence for perceptual masking of the discriminative morphine stimulus. Psychopharmacology (Berl) 98:212-221.
21. Gauvin DV, Peirce JM, Holloway FA (1994). Perceptual masking of the chlordiazepoxide discriminative cue by both caffeine and buspirone. Pharmacol Biochem Behav 47:153-159.
22. Giorgi O, Piras G, Corda MG (2007). The psychogenetically selected roman high- and low-avoidance rat lines: a model to study the individual vulnerability to drug addiction. Neurosci Biobehav Rev 31:148-163.
23. Gulley JM (2007). Individual differences in novelty- and cocaine-induced locomotor activity as predictors of food-reinforced operant behavior in two outbred rat strains. Pharmacol Biochem Behav 86:749-757.
24. Gulley JM, Hoover BR, Larson GA, Zahniser NR (2003). Individual differences in cocaine-induced locomotor activity in rats: behavioral characteristics, cocaine pharmacokinetics, and the dopamine transporter. Neuropsychopharmacology 28:2089-2101.
25. Gulley JM, Larson GA, Zahniser NR (2007). Using high-speed chronoamperometry coupled with local dopamine application to assess dopamine transporter function. In: Michael AC, Borland LM, editors. Electrochemical methods in neuroscience. Boca Raton, Florida: CRC Press, pp. 83-102.
26. Heidbreder CA, Babovic-Vuksanovic D, Shoaib M, Shippenberg TS (1995). Development of behavioral sensitization to cocaine: influence of kappa opioid receptor agonists. J Pharmacol Exp Ther 275:150-163.
27. Heinz A, Goldman D, Jones DW, Palmour R, Hommer D, Gorey JG, et al. (2000). Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 22:133-139.
28. Kamens HM, Burkhart-Kasch S, McKinnon CS, Li N, Reed C, Phillips TJ (2005). Sensitivity to psychostimulants in mice bred for high and low stimulation to methamphetamine. Genes Brain Behav 4:110-125.
29. Kleven MS, Koek W (1998). Discriminative stimulus properties of cocaine: Enhancement by monoamine reuptake blockers. J Pharmacol Exp Ther 284:1015-1025.
30. Kleven MS, Anthony EW, Woolverton WL (1990). Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 254:312-317.
31. Knuepfer MM, Mueller PJ (1999). Review of evidence for a novel model of cocaine-induced cardiovascular toxicity. Pharmacol Biochem Behav 63:489-500.
32. Kueh D, Baker LE (2007). Reinforcement schedule effects in rats trained to discriminate 3,4-methylenedioxymethamphetamine (MDMA) or cocaine. Psychopharmacology (Berl) 189:447-457.
33. Lambert NM, McLeod M, Schenk S (2006). Subjective responses to initial experience with cocaine: an exploration of the incentive-sensitization theory of drug abuse. Addiction 101:713-725.
34. Liu S, Cunningham KA (2006). Serotonin2C receptors (5-HT2C R) control expression of cocaine-induced conditioned hyperactivity. Drug Alcohol Depend 81:275-282.
35. Lott DC, Kim SJ, Cook EH Jr, de Wit H (2005). Dopamine transporter gene associated with diminished subjective response to amphetamine. Neuropsychopharmacology 30:602-609.
36. Lott DC, Kim SJ, Cook EH, de Wit H (2006). Serotonin transporter genotype and acute subjective response to amphetamine. Am J Addict 15:327-335.
37. Mandt BH, Schenk S, Zahniser NR, Allen RM (2008). Individual differences in cocaine-induced locomotor activity in male Sprague-Dawley rats and their acquisition of and motivation to self-administer cocaine. Psychopharmacology (Berl) [Epub ahead of print].
38. Marona-Lewicka D, Nichols DE (1997). 5-HT2A/2C receptor agonists potentiate the discriminative cue of (+ )-amphetamine in the rat. Neuropharmacology 36:1471-1475.
39. Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, Egan MF, et al. (2003). Catechol O-methyltransferase val1 58-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A 100:6186-6191.
40. Mill J, Asherson P, Browes C, D'Souza U, Craig I (2002). Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet 114:975-979.
41. Munzar P, Laufert MD, Kutkat SW, Novakova J, Goldberg SR (1999). Effects of various serotonin agonists, antagonists, and uptake inhibitors on the discriminative stimulus effects of methamphetamine in rats. J Pharmacol Exp Ther 291:239-250.
42. Munzar P, Justinova Z, Kutkat SW, Goldberg SR (2002). Differential involvement of 5-HT(2A) receptors in the discriminative-stimulus effects of cocaine and methamphetamine. Eur J Pharmacol 436:75-82.
43. Panlilio LV, Katz JL, Pickens RW, Schindler CW (2003). Variability of drug self-administration in rats. Psychopharmacology (Berl) 167:9-19.
44. Partridge B, Schenk S (1999). Context-independent sensitization to the locomotor-activating effects of cocaine. Pharmacol Biochem Behav 63:543-548.
45. Quinton MS, Gerak LR, Moerschbaecher JM, Winsauer PJ (2006). Effects of pregnanolone in rats discriminating cocaine. Pharmacol Biochem Behav 85:385-392.
46. Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987). Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219-1223.
47. Robinson TE, Browman KE, Crombag HS, Badiani A (1998). Modulation of the induction or expression of psychostimulant sensitization by the circumstances surrounding drug administration. Neurosci Biobehav Rev 22:347-354.
48. Sabeti J, Gerhardt GA, Zahniser NR (2002). Acute cocaine differentially alters accumbens and striatal dopamine clearance in low and high cocaine locomotor responders: behavioral and electrochemical recordings in freely moving rats. J Pharmacol Exp Ther 302:1201 -1211.
49. Sabeti J, Gerhardt GA, Zahniser NR (2003). Individual differences in cocaine- induced locomotor sensitization in low and high cocaine locomotor-responding rats are associated with differential inhibition of dopamine clearance in nucleus accumbens. J Pharmacol Exp Ther 305:180-190.
50. Saka E, Goodrich C, Harlan P, Madras BK, Graybiel AM (2004). Repetitive behaviors in monkeys are linked to specific striatal activation patterns. J Neurosci 24:7557-7565.
51. Schafer J, Brown SA (1991). Marijuana and cocaine effect expectancies and drug use patterns. J Consult Clin Psychol 59:558-565.
52. Seymour CM, Wagner JJ (2008). Simultaneous expression of cocaine-induced behavioral sensitization and conditioned place preference in individual rats. Brain Res 1213:57-68.
53. Sofuoglu M, Brown S, Babb DA, Hatsukami DK (2001). Depressive symptoms modulate the subjective and physiological response to cocaine in humans. Drug Alcohol Depend 63:131 -137.
54. Stanis JJ, Burns RM, Sherrill LK, Gulley JM (2008). Disparate cocaine-induced locomotion as a predictor of choice behavior in rats trained in a delay- discounting task. Drug Alcohol Depend 98:54-62.
55. Stoleman IP (1991). Measures of stimulus generalization in drug discrimination experiments. Behav Pharmacol 2:265-282.
56. Tornatzky W, Miczek KA (2000). Cocaine self-administration 'binges': transition from behavioral and autonomic regulation toward homeostatic dysregulation in rats. Psychopharmacology (Berl) 148:289-298.
57. Van Dyck CH, Malison RT, Jacobsen LK, Seibyl JP, Staley JK, Laruelle M, et al. (2005). Increased dopamine transporter availability associated with the 9-repeat allele of the SLC6A3 gene. J Nucl Med 46:745-751.
58. Veenstra-VanderWeele J, Qaadir A, Palmer AA, Cook EH Jr, de Wit H (2006). Association between the casein kinase 1 epsilon gene region and subjective response to D-amphetamine. Neuropsychopharmacology 31:1056-1063.
59. Volkow ND, Wang GJ, Fowler JS, Logan J, Gatley SJ, Hitzemann R, et al. (1997). Decreased striatal dopaminergic responsiveness in detoxified cocaine- dependent subjects. Nature 386:830-833.
60. Walsh SL, Cunningham KA (1997). Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine. Psychopharmacology (Berl) 130:41-58.